| Usher in the historical development opportunities | | | | become Beijing biomedical industry an important part. |
| Into the new century, life sciences and biotechnology | | | | With proprietary technology or exclusive varieties, |
| research continued to achieve a major breakthrough. | | | | strong profitability of these enterprises, marketing |
| This breakthrough, is agriculture, medicine, energy and | | | | margins are often as high as 50%. |
| chemical industry and the birth of a new birth of the | | | | Science and technology enterprises rely on innovation |
| industrial revolution, and thus lead to a new | | | | and development, has been widely recognized by |
| international division of labor. Accelerate the | | | | domestic and international capital markets, music |
| development of bio-industry in many countries has | | | | & Poor's health care, Tiantan Biological Products, |
| become a focus of economic development strategy. | | | | Beijing Sinovac, source de Biology, BIOSINO, Tong |
| Especially in the current circumstances, in order to | | | | Ren Tang Science and Technology, Beijing |
| cope with the international financial crisis, countries | | | | Double-Crane Pharmaceutical and other biomedical 16 |
| have in accelerating the development of new | | | | science and technology enterprises have in New |
| economic growth points, in order to revive the | | | | York, Singapore and China's Hong Kong, Shanghai, |
| economy after the crisis to prepare bio-industry has | | | | Shenzhen and other domestic and foreign stock |
| become an important option in many countries. | | | | exchange listing is successful, the current market |
| The NDRC official said that at present, China has | | | | value of more than 100 billion yuan. |
| entered a well-off society and accelerating the | | | | Third, Beijing has become the world's biomedical |
| modernization of the new stage. Compared with | | | | industry, the focus of the development of cities. |
| other countries, China in the future supply of | | | | Beijing a strong scientific and technological resources, |
| resources faced by the "bottleneck" is more | | | | clinical resources and markets to attract a large |
| prominent, and eco-environmental constraints become | | | | number of domestic and foreign enterprises and the |
| more pronounced. Therefore, to accelerate the | | | | development of R & D institutions in Beijing. |
| bio-industry development, for our country to ease | | | | Since 2003, Beijing biomedical field has attracted 77 |
| the population, health, resources, and environment | | | | foreign investment projects, with a total investment |
| bottleneck constraints, promoting steady economic | | | | amounting to 13.808 billion yuan. France's Sanofi - |
| growth, the protection of national security has special | | | | Aventis, Procter & Gamble and the United |
| strategic significance. | | | | States, Genzyme, Novo Nordisk of Denmark as well |
| It is in this context, with the health care system and | | | | as the Yangtze River in Jiangsu, Jilin amendment, |
| the steady implementation of the policy of expanding | | | | Hebei Yiling, medium-well-known enterprises in Jiangxi, |
| domestic demand, and "Science and Technology | | | | Beijing has become a major force in the field of |
| Beijing" action plan "Zhongguancun national | | | | bio-medicine . |
| independent innovation demonstration area | | | | Fourth, a large number of enterprises started to go |
| construction," efforts to promote the Beijing | | | | global. Beijing internationalization of biomedical industry |
| bio-pharmaceutical industry has become the capital of | | | | with a solid foundation and a good start in recent |
| tune structure, to maintain growth, an important | | | | years, a number of good development trend, the |
| force in promoting the people's livelihood, but also | | | | backbone of a high degree of brand recognition to |
| ushered in a rare historical opportunity for | | | | the international companies are on the road has a |
| development. | | | | good performance: Beijing SECCO medicine to apply |
| Industry form a "capital characteristics" | | | | for registration in the United States has begun its |
| Learned from the Beijing Science and Technology | | | | own production of generic drugs; Beijing Zizhu |
| Commission, in recent years, Beijing's biomedical | | | | Pharmaceutical raw material medicine and preparation |
| industry to rely on scientific and technological | | | | products have been marketing more than 20 |
| innovation to maintain a steady and relatively fast | | | | countries; Tong Ren Tang Group has opened a |
| growth, industry continues to grow. After years of | | | | number of overseas branches of overseas registered |
| development, Beijing's biomedical industry in the | | | | more than 400 varieties, and so on. |
| industrial structure, innovation, development potential, | | | | Depicts a beautiful blueprint for the development |
| spatial layout has formed a significant "capital | | | | Beijing national bio-industry base of the cluster |
| characteristics." | | | | pattern and degree of industrial agglomeration leading |
| One is medium-sized state-owned enterprises as the | | | | the country, formed the Zhongguancun Life Science |
| backbone of the biomedical innovation system, Beijing | | | | Park as an industry innovation center, Beijing |
| has taken initial shape. In recent years, Beijing's focus | | | | Economic and Technological Development Zone as an |
| on promoting the Beijing Pharmaceutical Group, Beijing | | | | international manufacturing center, to Daxing industrial |
| Tong Ren Tang Group, China's three major groups in | | | | base for the emerging bio-pharmaceutical |
| biotechnology innovation system. At present, three | | | | manufacturing industry gathering area "three-point |
| major groups in the capital, technological resources | | | | support, collaborative development" space layout. At |
| and the close association, established a number of | | | | present, the three parks the city's total |
| national engineering centers and business technology | | | | bio-pharmaceutical industry for more than 50% of |
| center, marking the Beijing chemical medicine, Chinese | | | | the total output value has become host to the |
| medicine, bio-pharmaceuticals and other areas has | | | | Beijing bio-pharmaceutical industry a pillar industry |
| been basically built a business-oriented innovation | | | | represent an important platform. |
| system. | | | | In recent years, Beijing continue to integrate its own |
| The engineering and technical centers to assume and | | | | scientific and technological resources, and strive to |
| carry out a new product development, great variety | | | | create a favorable environment for industrial |
| of re-development, production process and so a lot | | | | development, breaking the policy bottlenecks, capital, |
| of work to upgrade key technologies for enterprise | | | | technology professionals rely on superiority and urge |
| development and growth of the industry has played | | | | enterprises to strengthen independent innovation |
| an active role. Now, key enterprises has become a | | | | capability, build the core competitiveness of the |
| bio-pharmaceutical industry to promote the | | | | efforts have started to bear fruit enterprise cluster |
| development of Beijing's most important strength. In | | | | efficiency increased daily. |
| 2008, the north of the Pharmaceutical Group, Tong | | | | In the future, Beijing will continue to optimize the |
| Ren Tang Group, Tiantan Biological Products and | | | | market, capital and human resources areas such as |
| other key enterprises, represented by the completion | | | | allocation of resources to scientific and technological |
| of sales of 22.8 billion, for the industry contributed | | | | innovation as a means to further enhance the market |
| 75% of industrial output. | | | | competitiveness of key enterprises to further |
| Second, small and medium innovative enterprises in | | | | promote the key enterprises and high-end varieties |
| support of Beijing's sustainable development, | | | | into the United States, Europe and other international |
| bio-pharmaceutical industry plays an important role in | | | | mainstream market to further promote the |
| the process. By Ted pharmaceutical, source de bio, | | | | expansion of market share in key products and |
| music & Poor's health care, medicine, and so | | | | further promote the exclusive varieties to market |
| pairs of herons, represented by a group of | | | | faster. |
| proprietary technology, high-growth enterprises have | | | | |